Evidence-based approaches to pain in advanced cancer

Cancer Journal

Volumn 16, Issue 5, 2010, Pages 500-506

  Dy, Sydney Morss ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cancer pain; neuropathic pain; opioids; radiotherapy; spinal cord compression

Indexed keywords

17 METHYLNALTREXONE; ALVIMOPAN; ANTIEMETIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CODEINE; CORTICOSTEROID; DIURETIC AGENT; DULOXETINE; GABAPENTIN; HYDROMORPHONE; LACTULOSE; LAMOTRIGINE; LIDOCAINE; MACROGOL; METHADONE; MEXILETINE; MORPHINE; MU OPIATE RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PHENOTHIAZINE; PREGABALIN; PROTON PUMP INHIBITOR; SENNA EXTRACT; SEROTONIN 3 AGONIST; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ACUPUNCTURE; ADVANCED CANCER; BONE METASTASIS; BONE PAIN; CANCER PAIN; CANCER RADIOTHERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; CONTINUOUS INFUSION; DELIRIUM; DRUG DOSE TITRATION; EVIDENCE BASED MEDICINE; HEALTH EDUCATION; HUMAN; LOW DRUG DOSE; NAUSEA; NAUSEA AND VOMITING; NEUROPATHIC PAIN; PAIN ASSESSMENT; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PRURITUS; RASH; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SOCIAL PSYCHOLOGY; SPINAL CORD COMPRESSION; STOMACH DISEASE; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; URINE RETENTION;

ANALGESICS, OPIOID; BONE NEOPLASMS; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; PAIN; PALLIATIVE CARE; SPINAL CORD COMPRESSION;

EID: 77958126793     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3181f45853     Document Type: Review

References (51)

1. Angell M. The quality of mercy. NEJM. 1982;306:98-99. (Pubitemid 12082565)
2. Teunissen SC, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007;34:94-104. (Pubitemid 46970881)
3. Goudas LC, Bloch R, Gialeli-Goudas M, et al. The epidemiology of cancer pain. Cancer Invest. 2005;23:182-190. (Pubitemid 40463916)
4. Lorenz KA, Dy SM, Naeim A, et al. Quality measures for supportive cancer care: the Cancer Quality-ASSIST (Assessing Symptoms Side Effects and Indicators of Supportive Treatment) project. J Pain Symptom Manage. 2009;37:943-964.
5. Dy SM, Asch SM, Naeim A, et al. Evidence-based standards for cancer pain management. J Clin Oncol. 2008;26:3879-3885.
6. World Health Organization. WHO's Pain Ladder. Available at: www.who. int/cancer/palliative/painladder/en/.
7. National Comprehensive Cancer Network. Adult Cancer Pain. Available at: www.nccn.org.
8. Marinangeli F, Ciccozzi A, Leonardis M, et al. Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage. 2004;27:409-416. (Pubitemid 38569646)
9. Nicholson AB. Methadone for cancer pain. Cochrane Database Syst Rev. 2007;4:CD003971.
10. Mercadante S, Porzio G, Ferrera P, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain. 2008;12:1040-1046.
11. Davis MP, Weissman DE, Arnold RM. Opioid dose titration for severe cancer pain: a systematic evidence-based review. J Palliat Med. 2004; 7:462-468.
12. McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003;4:231-256. (Pubitemid 36807905)
13. Kurita GP, Lundorff L, Pimenta CA. The cognitive effects of opioids in cancer: a systematic review. Support Care Cancer. 2009;17:11-21.
14. Ahmedzai SH, Boland J. Constipation in people prescribed opioids. Clin Evid (Online). 2007;6:2407.
15. McNicol ED, Boyce D, Schumann R, et al. mu-Opioid antagonists for opioid-induced bowel dysfunction. Cochrane Database Syst Rev. 2009; 2:CD006332. (Pubitemid 351807375)
16. Woolery M, Bisanz A, Lyons HF, et al. Putting evidence into practice: evidence-based interventions for the prevention and management of constipation in patients with cancer. Clin J Oncol Nurs. 2008;12: 317-337.
17. Pargeon KL, Hailey BJ. Barriers to effective cancer pain management: a review of the literature. J Pain Symptom Manage. 1999;18:358-368. (Pubitemid 29528472)
18. Flemming K. The use of morphine to treat cancer-related pain: a synthesis of quantitative and qualitative research. J Pain Symptom Manage. 2010;39:139-154.
19. Miaskowski C. The use of risk-management approaches to protect patients with cancer-related pain and their healthcare providers. Oncol Nurs Forum. 2008;35:20-24.
20. Bennett MI, Bagnall AM, José Closs S. How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. Pain. 2009;143:192-199.
21. Devine EC. Meta-analysis of the effect of psychoeducational interventions on pain in adults with cancer. Oncol Nurs Forum. 2003;30:75-89.
22. Bardia A, Barton DL, Prokop LJ, et al. Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol. 2006;24:5457-5464. (Pubitemid 46623180)
23. Madsen MV, GLtzsche PC, Hró bjartsson A. Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups. BMJ. 2009; 338:a3115.
24. Jost LM. ESMO minimum clinical recommendations for the management of cancer pain. Ann Oncol. 2005;16:i83Yi85.
25. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA. 2005;293:3043-3052. (Pubitemid 40965075)
26. Caraceni A, Zecca E, Bonezzi C, et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol. 2004;22:2909-2917. (Pubitemid 41079911)
27. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352:1324-1334. (Pubitemid 40411499)
28. Keskinbora K, Pekel AF, Aydinli I. Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial. J Pain Symptom Manage. 2007;34:183-189. (Pubitemid 47088905)
29. Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85:S3YS14.
30. Challapalli V, Tremont-Lukats IW, McNicol ED, et al. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev. 2005;4:CD003345.
31. Kaley TJ, Deangelis LM. Therapy of chemotherapy-induced peripheral neuropathy. Br J Haematol. 2009;145:3-14.
32. Mhaskar R, Redzepovic J, Wheatley K, et al. Bisphosphonates in multiple myeloma. Cochrane Database Syst Rev. 2010;3:CD003188.
33. Pavlakis N, Schmidt RL, Stockler MR. Bisphosphonates for breast cancer. Cochrane Database Syst Rev. 2005;3:CD003474.
34. Yuen KK, Shelley M, Sze WM, et al. Bisphosphonates for advanced prostate cancer. Cochrane Database Syst Rev. 2006;4:CD006250. (Pubitemid 46841161)
35. Machado M, Cruz LS, Tannus G, et al. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials. Clin Ther. 2009;31:962-979.
36. Rosen LS, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trialVthe Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol. 2003;21:3150-3157. (Pubitemid 46606297)
37. Bell R. Efficacy of ibandronate in metastatic bone disease: review of clinical data. Oncologist. 2005;10:8-13. (Pubitemid 41504871)
38. Food and Drug Administration (FDA). Information for healthcare professionals: bisphosphonates, 2008. Available at: www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124165.htm. Accessed August 13, 2010.
39. Woo SB, Hellstein JW, Kalmar JR. Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753-761. (Pubitemid 46780635)
40. Khan AA, Sándor GK, Dore E, et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol. 2008;35:1391-1397. (Pubitemid 352000790)
41. Amouzegar-Hashemi F, Behrouzi H, Kazemian A, et al. Single versus multiple fractions of palliative radiotherapy for bone metastases: a randomized clinical trial in Iranian patients. Curr Oncol. 2008;15:151.
42. Foro Arnalot P, Fontanals AV, Galcerán JC, et al. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol. 2008;89:150-155.
43. Bauman G, Charette M, Reid R, et al. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review. Radiother Oncol. 2005;75:258-270. (Pubitemid 41007970)
44. Finlay IG, Mason MD, Shelley M. Radioisotopes for the palliation of metastatic bone cancer: a systematic review. Lancet Oncol. 2005;6: 392-400. (Pubitemid 40753745)
45. Bouza C, López-Cuadrado T, Cediel P, et al. Balloon kyphoplasty in malignant spinal fractures: a systematic review and meta-analysis. BMC Palliat Care. 2009;8:12.
46. Kallmes DF, Comstock BA, Heagerty PJ, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009; 361:569-579.
47. Buchbinder R, Osborne RH, Ebeling PR, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361:557-568.
48. Loblaw DA, Perry J, Chambers A, et al. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol. 2005;23:2028-2037. (Pubitemid 46211383)
49. George R, Jeba J, Ramkumar G, et al. Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database Syst Rev. 2008;4:CD006716.
50. Myers J, Chan V, Jarvis V, et al. Intraspinal techniques for pain management in cancer patients: a systematic review. Support Care Cancer. 2010;18:137-149.
51. Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol. 2007;102:430-438.